As reported, miR-223-3p inhibits fibroblast-like synoviocyte pyroptosis and proliferation and inflammatory responses of fibroblast-like synoviocyte in rheumatoid arthritis by targeting NLRP3 [47, 48]. Here, NLRP3 is linked to rheumatoid arthritis.